InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-29.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Michel Masson, 监事会主席. Insider active across 1 company, notably NEOLIFE. Cumulatively, 1 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €18k. History available since 16 June 2023. The latest transaction was disclosed on 16 June 2023 (Acquisition). Regulator: AMF. The full history is free.
Companies and markets linked to Michel Masson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
160,000 股@ €0.113100.0% 占其流量ActionEuronext Growth ParisISIN FR00116360832023DD916033
标准退出：2023年9月14日 (T+90)
1 条申报中的 1 条
About Michel Masson
Michel Masson is the Vice Chairman of the Supervisory Board at Neolife, a company specializing in health solutions. In his role, he participates in overseeing operations and making strategic decisions. Michel brings his expertise in management and business development, contributing to Neolife's performance and growth.
